People
  1. Academic experts
  2. Research students
  3. Students
  4. Alumni
  5. Senior people at City
  6. Non-academic staff
  7. Honorary graduates
People

portrait of Dr Stanley Mutsatsa

Dr Stanley Mutsatsa

Senior Lecturer

School of Health Sciences, Division of Nursing

Contact Information

Contact

Visit Stanley Mutsatsa

MG22, Myddelton Street Building

Postal Address

City, University of London
Northampton Square
London
EC1V 0HB
United Kingdom

About

Overview

Stanley has worked in various fields of mental health nursing for many years. He obtained his first degree in Chemical Engineering degree before he went on to study for a masters in Clinical Mental Health at Kings College , Institute of Psychiatry London before taking up a post as a Research Associate at Imperial College London where he completed his PhD in Psychological Medicine. After completion of his doctorate degree, he moved back to Institute of Psychiatry, London and then to London South Bank University before joing City University of London in 2015.

Qualifications

  1. PhD Psychological Medicine, Imperial College London, United Kingdom
  2. MSc Clinical Mental Health, Kings College, Institute of Psychology, Psychiatry and Neuroscience(IOPPN), United Kingdom
  3. BEng(Hons) Chemical Engineering, London South Bank University, United Kingdom
  4. Registered Mental Nurse, Southend Hospital, United Kingdom
  5. Post Graduate Certificate in Higher education, London South Bank University, United Kingdom

Publications

Books (3)

  1. Mutsatsa, S. (2016). Medicines Management in Mental Health Nursing. Learning Matters. ISBN 978-1-4739-6584-3.
  2. Mutsatsa, S. (2015). Physical Healthcare and Promotion in Mental Health Nursing. Learning Matters. ISBN 978-1-4462-6818-6.
  3. Mutsatsa, S. (2011). Medicines Management in Mental Health Nursing. SAGE. ISBN 978-0-85725-049-0.

Conference papers and proceedings (7)

  1. Harrison, I., Barnes, T.R., Leeson, V., Mutsatsa, S. and Joyce, E.M. (2009). THE IMPACT OF CANNABIS USE ON ILLNESS COURSE IN FIRST EPISODE PSYCHOSIS.
  2. Joyce, E.M., Leeson, V.C., Mutsatsa, S.H., Watt, H.C., Hutton, S.B., Ron, M.A. … Barnes, T.R. (2007). Is the effect of dup on social function mediated via negative symptoms? A one-year follow-up study of first-episode psychosis.
  3. Kapasi, M., Hutton, S., Mutsatsa, S., Barnes, T. and Joyce, E. (2004). Treatment effects of conventional and typical antipsychotics on cognition following a first episode of schizophrenia.
  4. Kapasi, M., Hutton, S., Mutsatsa, S., Barnes, T. and Joyce, E. (2004). Treatment effects of conventional and typical antipsychotics on cognition following a first episode of schizophrenia.
  5. Bagary, M.S., Foong, J., Cercignani, M., Symms, M., Barker, G., Hutton, S. … Ron, M.A. (2004). Structural brain abnormalities may be progressive in schizophrenia.
  6. Bagary, M.S., Symms, M., Barker, G., Mutsatsa, S., Hutton, S., Joyce, E. … Ron, M.A. (2002). Voxel-based morphometric analysis of structural brain abnormalities in first episode schizophrenia (FES).
  7. Barnes, T.R.E., Hutton, S.B., Chapman, M.J., Mutsatsa, S., Puri, B.K. and Joyce, E.M. (1999). West London first-episode study of schizophrenia: Clinical correlates of duration of untreated psychosis at first presentation to psychiatric services.

Journal articles (47)

  1. Gaughran, F., Stahl, D., Ismail, K., Greenwood, K., Atakan, Z., Gardner-Sood, P. … Goldin, M. (2017). Randomised control trial of the effectiveness of an integrated psychosocial health promotion intervention aimed at improving health and reducing substance use in established psychosis (IMPaCT). BMC Psychiatry, 17(1). doi:10.1186/s12888-017-1571-0.
  2. Heslin, M., Patel, A., Stahl, D., Gardner-Sood, P., Mushore, M., Smith, S. … Gaughran, F. (2017). Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion. BMC PSYCHIATRY, 17. doi:10.1186/s12888-017-1570-1.
  3. Mutsatsa, S. (2017). The use of long-acting injectable antipsychotic medication. British Journal of Mental Health Nursing, 6(3), pp. 114–117. doi:10.12968/bjmh.2017.6.3.114.
  4. Mutsatsa, S. (2016). A guide to medication adherence in depression. British Journal of Mental Health Nursing, 5(6), pp. 259–261. doi:10.12968/bjmh.2016.5.6.259.
  5. Mutsatsa, S. (2016). The use of low-dose antipsychotic medication. Nursing and Residential Care, 18(4), pp. 188–190. doi:10.12968/nrec.2016.18.4.188.
  6. Phillips, Y. and Mutsatsa, S. (2014). Depression: Current treatments with low-cost strategies. British Journal of Mental Health Nursing, 3(5), pp. 210–216. doi:10.12968/bjmh.2014.3.5.210.
  7. Mutsatsa, S., Mushore, M., Ncube, K. and Currid, T. (2013). Vitamin D: the role of the sunshine vitamin. British Journal of Mental Health Nursing, 2(4), pp. 182–187. doi:10.12968/bjmh.2013.2.4.182.
  8. Mutsatsa, S. and Bressington, D. (2013). Oral liquid antipsychotic formulation in the treatment of psychosis. British Journal of Mental Health Nursing, 2(3), pp. 126–127. doi:10.12968/bjmh.2013.2.3.126.
  9. Rooks, J. and Mutsatsa, S. (2013). Is there a crisis in inpatient mental health care? British Journal of Mental Health Nursing, 2(3), pp. 134–138. doi:10.12968/bjmh.2013.2.3.134.
  10. Currid, T.J. and Mutsatsa, S. (2013). What effect will pharmacogenomics have on mental health nursing? Neuropsychiatry, 3(3), pp. 309–320. doi:10.2217/npy.13.33.
  11. Mutsatsa, S. and Bressington, D. (2013). Antipsychotics in the treatment of psychosis: risks and benefits. British Journal of Mental Health Nursing, 2(1), pp. 52–57.
  12. Mutsatsa, S. and Currid, T.J. (2013). Pharmacogenetics: A reality or misplaced optimism? Journal of Psychiatric and Mental Health Nursing, 20(4), pp. 314–320. doi:10.1111/j.1365-2850.2012.01910.x.
  13. Leeson, V.C., Barnes, T.R.E., Harrison, M., Matheson, E., Harrison, I., Mutsatsa, S.H. … Joyce, E.M. (2010). The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophrenia Bulletin, 36(2), pp. 400–409. doi:10.1093/schbul/sbn100.
  14. Barnes, T.R.E., Leeson, V.C., Mutsatsa, S.H., Watt, H.C., Hutton, S.B. and Joyce, E.M. (2008). Duration of untreated psychosis and social function: 1-Year follow-up study of first-episode schizophrenia. British Journal of Psychiatry, 193(3), pp. 203–209. doi:10.1192/bjp.bp.108.049718.
  15. Leeson, V., Kapasi, M., Matheson, E., Harrison, I., Mutsatsa, S., Barmes, T.R.E. … Joyce, E.M. (2008). Processing speed in first episode psychosis: selectively impaired and a predictor of one year clinical outcome. Schizophrenia Research, 108(1-3), pp. 141–142.
  16. Harrison, I., Joyce, E.M., Leeson, V.C., Kapasi, M., Mutsatsa, S., Matheson, E. … Barnes, T.R.E. (2008). Cannabis use and cognitive function in first episode psychosis. Schizophrenia Research, 102(1-3), pp. 248–248.
  17. Harrison, I., Joyce, E.M., Leeson, V.C., Harrison, M., Mutsatsa, S.H., Matheson, E. … Barnes, T.R. (2008). CANNABIS USE AND COGNITIVE FUNCTION IN FIRST EPISODE PSYCHOSIS. Schizophrenia Research, 102(1-3), pp. 248–248. doi:10.1016/S0920-9964(08)70748-5.
  18. Harrison, I., Joyce, E.M., Mutsatsa, S.H., Hutton, S.B., Huddy, V., Kapasi, M. … Barnes, T.R.E. (2008). Naturalistic follow-up of co-morbid substance use in schizophrenia: The West London first-episode study. Psychological Medicine, 38(1), pp. 79–88. doi:10.1017/S0033291707000797.
  19. Huddy, V.C., Hodgson, T.L., Kapasi, M., Mutsatsa, S.H., Harrison, I., Barnes, T.R.E. … Joyce, E.M. (2007). Gaze Strategies During Planning in First-Episode Psychosis. Journal of Abnormal Psychology, 116(3), pp. 589–598. doi:10.1037/0021-843X.116.3.589.
  20. Harrison, I., Joyce, E.M., Mutsatsa, S. and Barnes, T.R.E. (2006). Symptom correlates of cannabis use in first-episode psychosis. SCHIZOPHRENIA RESEARCH, 86. doi:10.1016/S0920-9964(06)70303-6.
  21. Barnes, T.R.E., Leeson, V.C., Mutsatsa, S.M., Hutton, S.B. and Joyce, E.M. (2006). Duration of untreated psychosis as a predictor of initial treatment response in first episode schizophrenia. SCHIZOPHRENIA RESEARCH, 86. doi:10.1016/S0920-9964(06)70343-7.
  22. Mutsatsa, S.H., Joyce, E.M., Hutton, S.B. and Barnes, T.R.E. (2006). Relationship between insight, cognitive function, social function and symptomatology in schizophrenia: The West London first episode study. European Archives of Psychiatry and Clinical Neuroscience, 256(6), pp. 356–363. doi:10.1007/s00406-006-0645-7.
  23. Kapasi, M., Hutton, S., Mutsatsa, S., Barnes, T.R.E. and Joyce, E.M. (2006). Measuring current and premorbid IQ in healthy volunteers and first episode psychosis: a comparison of NART, WTAR and short WAIS III. Schizophrenia Research, (67), pp. 206–206.
  24. Barnes, T.R.E., Mutsatsa, S.H., Hutton, S.B., Watt, H.C. and Joyce, E.M. (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry, 188(MAR.), pp. 237–242. doi:10.1192/bjp.bp.104.007237.
  25. Joyce, E.M., Hutton, S.B., Mutsatsa, S.H. and Barnes, T.R.E. (2005). Cognitive heterogeneity in first-episode schizophrenia. British Journal of Psychiatry, 187(DEC.), pp. 516–522. doi:10.1192/bjp.187.6.516.
  26. Bagary, M.S., Hutton, S.B., Symms, M.R., Barker, G.J., Mutsatsa, S.H., Barnes, T.R.E. … Ron, M.A. (2004). Structural neural networks subserving oculomotor function in first-episode schizophrenia. Biological Psychiatry, 56(9), pp. 620–627. doi:10.1016/j.biopsych.2004.08.017.
  27. Harrison, I., Joyce, E.M., Hutton, S., Mutsatsa, S., Huddy, I., Kapasi, M. … Barnes, T.R. (2004). Naturalistic follow up study of co morbid substance use in schizophrenia: The West London first episode study. Journal of Psychopharmacology, 18.
  28. Huddy, V., Hodgson, T.L., Mutsatsa, S., Harrison, I., Barnes, T.R. and Joyce, E.M. (2004). Saccadic set shifting and reward -dependent inhibition of return in first episode psychosis. Schizophrenia Research, 67, pp. 135–135.
  29. Kapsai, M., Hutton, S., Mutsatsa, S., Barnes, T.R. and Joyce, E. (2004). The effect of treatment with atypical and conventional antipsychotics on cognition following a first episode of schizophrenia: The West London Study. Schizophrenia Research, 67, pp. 206–206.
  30. Harrison, I., Joyce, E.M., Mutsatsa, S., Hutton, S.B., Huddy, V. and Barnes, T.R. (2004). Follow up of comorbid substance use in in schizophrenia:the West London first episode study. Schizophrenia Research, 67, pp. 216–217.
  31. Mutsatsa, S.H., Joyce, E.M., Hutton, S.B., Webb, E., Gibbins, H., Paul, S. … Barnes, T.R.E. (2003). Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatrica Scandinavica, 108(6), pp. 439–446. doi:10.1046/j.0001-690X.2003.00193.x.
  32. Barnes, T.R., mutsatsa, S., Hutton, S.B. and Joyce, E.B. (2003). Clinical correlates of comorbid substance use in first episode schizophrenia. Schizophrenia Research, 60, pp. 11–11.
  33. Bagary, M.S., Symms, M.R., Barker, G.J., Mutsatsa, S.H., Joyce, E.M. and Ron, M.A. (2003). Gray and white matter brain abnormalities in first-episode schizophrenia inferred from magnetization transfer imaging. Archives of General Psychiatry, 60(8), pp. 779–788. doi:10.1001/archpsyc.60.8.779.
  34. Bagary, M., Hutton, S., Symms, M., Barker, G., Mutsatsa, S., Joyce, E. … Ron, M. (2003). Oculomotor, cognitive and symptom correlates in first-episode schizophrenia using magnetization transfer imaging and volumetric MRI. Schizophrenia Research, 60(1), pp. 189–189. doi:10.1016/S0920-9964(03)81095-2.
  35. Barnes, T.R.E., Mutsatsa, S., Hutton, S.B. and Joyce, E.M. (2003). Clinical correlates of comorbid substance use in first episode schizophrenia. Schizophrenia Research, 60(1), pp. 11–11.
  36. Joyce, E., Hutton, S., Mutsatsa, S., Gibbins, H., Webb, E., Paul, S. … Barnes, T. (2002). Executive dysfunction in first-episode schizophrenia and relationship to duration of untreated psychosis: The West London Study. British Journal of Psychiatry, 181(SUPPL. 43).
  37. Mutsatsa, S., Hutton, S.B., Webb, E., Paul, S., Joyce, E. and Barnes, T.R. (2002). Attitudes towards medication in schizophrenia : the West London first episode study. Schizophrenia Research, 53, pp. 205–205.
  38. Joyce, E.M., Hutton, S.B., Mutsatsa, S., Webb, E., Paul, S. and Barnes, T.R. (2002). Contribution of IQ to risk of schizophrenia and cognitive profile at first episode. Schizophrenia Research, 53, pp. 140–140.
  39. Joyce, E.M., Hutton, S., Mutsatsa, S., Webb, E., Paul, S. and Barnes, T.R. (2002). Contribution of IQ to risk of schizophrenia and cognitive profile at first episode schizophrenia The West London Study. Schizophrenia Research, 53, pp. 140–140.
  40. Mutsatsa, S. and Rinomhota, S. (2002). Nursing and extrapyramidal symptoms: a response to Clarke. Journal of psychiatric and mental health nursing, 9(2), pp. 221–225.
  41. Mutsatsa, S., Hutton, S.B., Gibbins, H., Dibnah, C., Joyce, E.M. and Barnes, T.R. (2001). Clinical correlates of insight in first episode schizophrenia. Schizophrenia Research, 49, pp. 18–18.
  42. Barnes, T.R.E., Hutton, S.B., Chapman, M.J., Mutsatsa, S., Puri, B.K. and Joyce, E.M. (2000). West London first-episode study of schizophrenia: Clinical correlates of duration of untreated psychosis. British Journal of Psychiatry, 177(SEPT), pp. 207–211. doi:10.1192/bjp.177.3.207.
  43. Hutton, S.B., Cuthbert, I., Mutsatsa, S., Kennard, C., Barnes, T.R. and Joyce, E.M. (2000). Saccadic distractibility in first episode schizophrenia. Schizophrenia Research, 41, pp. 41–41.
  44. Hutton, S.B., Cuthbert, I., Mutsatsa, S., Kennard, C., Barnes, T.R.E. and Joyce, E.M. (2000). The effects of typical and atypical neuroleptics on neuropsychological and oculomotor function in first-episode schizophrenia. SCHIZOPHRENIA RESEARCH, 41(1), pp. 40–40. doi:10.1016/S0920-9964(00)90385-2.
  45. Hutton, S.B., Cuthbert, I., Mutsatsa, S., Kennard, C., Barnes, T.R.E. and Joyce, E.M. (2000). Antisaccade and smooth pursuit performance in patients with schizophrenia and obsessive compulsive disorder. SCHIZOPHRENIA RESEARCH, 41(1), pp. 154–154. doi:10.1016/S0920-9964(00)90676-5.
  46. Joyce, E.M., Hutton, S.B., Barber, F.Z., Cuthbert, I., Mutsatsa, S., Gibbins, H. … Barnes, T.R.E. (2000). Relationship between IQ and memory and executive function in first episode schizophrenia. SCHIZOPHRENIA RESEARCH, 41(1), pp. 276–276. doi:10.1016/S0920-9964(00)90996-4.
  47. Mutsatsa, S., Barnes, T., Hutton, S., Cuthbert, I. and Joyce, E. (2000). A cross-sectional study of medication compliance: The west London first-episode schizophrenia study. Schizophrenia Research, 41(1), pp. 223–223. doi:10.1016/S0920-9964(00)90858-2.

Other Activities

Keynote lectures/speeches (3)

  1. .
  2. Non medical prescribing in mental health. Manchester, UK (2016).
  3. Non-Medical Precribing in Mental health. Bristol (2016).